60 participants
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-06-15
- Start Date:
- 2026-04-30
- Completion:
- 2027-06-30
Conditions
- Type 2 Diabetes
Interventions
- DRUG
No Results Yet